Arash Aryana, MD
Clinical Cardiac Electrophysiology · Sacramento, CANPI 1548279672
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (48.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Abbott at 34.5% of the total. Reporting peaked in 2019 at $133,462 and has fallen 80.7% since, to $25,802 in 2025. Among clinical cardiac electrophysiology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 539 payments — averaging $711.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$132K
- Medtronic$85K
- Biosense Webster, Inc.$66K
- Boston Scientific$29K
- Johnson & Johnson$29K
- Medical Device Business Services, Inc.$19K
- plus $23K from 9 others
Across 242 payments — averaging $8128.49 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$1.5M
- Abbott$170K
- Medical Device Business Services, Inc.$131K
- Boston Scientific$54K
- Cvrx, Inc.$25K
- Biosense Webster, Inc.$24K
- plus $19K from 1 others
What the payments were for
- Consulting fees$184,29948%
- Speaking & faculty fees$127,48233%
- Travel & lodging$57,41415%
- Food & beverage$13,8074%
- Education$2770%
- Gifts$1660%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 151 | $132,097 |
| Medtronic(2 entities) | 159 | $85,239 |
| Biosense Webster, Inc. | 82 | $65,557 |
| Boston Scientific | 63 | $29,347 |
| Johnson & Johnson | 30 | $29,163 |
| Medical Device Business Services, Inc. | 8 | $18,650 |
| Philips North America LLC | 6 | $11,654 |
| Atricure, Inc. | 5 | $6,235 |
| Biotronik Inc. | 20 | $4,846 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $233 |
| Cvrx, Inc. | 3 | $144 |
| Baxter Healthcare | 3 | $92 |
| Acutus Medical, Inc. | 2 | $85 |
| Cardiva Medical, Inc. | 3 | $83 |
| Novo Nordisk | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Agilis NxT EP Introducer$68,425
- Carto 3 System$53,728
- AGILIS$42,183
- Arctic Front$41,095
- XARELTO$28,881
- Carto 3$15,965
- Spectranetics Undiv$11,567
- Carto Smarttouch$7,257
- HeartMate 3 Left Ventricular Assist Device$6,445
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$6,000
- ENSITE PRECISION$5,159
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$3,598
- CLINICAL TRIAL PRODUCT$3,150
- AVEIR$2,911
- Lasso$2,100
- DIAMONDTEMP BIDIRECTIONAL ABLATION CATHETER$1,330
- CryoFlex$1,017
- PulseSelect$955
- Carto CFAE$700
- CartoSound$700
How this compares
$383,444 in reported general payments places this provider in the 95th percentile of 290 clinical cardiac electrophysiology providers in California.
See all clinical cardiac electrophysiology providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 139 | $119,612 |
| XareltoRivaroxaban | 62 | $62,310 |
| MultaqDronedarone Hcl | 19 | $23,749 |
| Flecainide Acetate | 19 | $2,305 |
| Amiodarone Hcl | 40 | $783 |
| Metoprolol Succinate | 25 | $385 |
| SotalolSotalol Hcl | 12 | $325 |
| Warfarin Sodium | 14 | $65 |
| Metoprolol Tartrate | 11 | $25 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $29,163 | $62,31062 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 290 clinical cardiac electrophysiology providers in California.
Other clinical cardiac electrophysiology in Sacramento
- Mark BowersSacramento$125K
- Niailah OchaiSacramento$95K
- Shephal DoshiSanta Monica$2.1M
- Jonathan HsuSan Diego$1.2M
- Leslie SaxonLos Angeles$1.1M
- Rahul BhardwajLoma Linda$935K
- Nicholas Olsonla Jolla$801K
- Jonathan DukesVentura$775K
- Brett GidneySanta Barbara$756K
- John Rogersla Jolla$738K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.